VIM (Vimentin) variants and mutations
VIM (also known as Vimentin) is a human protein-coding gene encoding a vimentin protein. It forms intermediate filaments that provide structural resilience and organize organelles in mesenchymal and migratory cells. Altered expression is a hallmark of epithelial-to-mesenchymal transition and tissue injury, while rare pathogenic variants can cause cataract or other tissue-specific phenotypes. This analysis covers 1,040 VIM variants and mutations. Of these, 75% have computational variant effect predictions. Disease context includes dengue disease, early-onset non-syndromic cataract, and Partial congenital cataract. Example VIM variants include M1?, S2P, and S2S.
Variant analysis overview
- Gene: VIM
- Protein: Vimentin
- UniProt accession: P08670
- Organism: Homo sapiens
- Variants analyzed: 1040
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 686 unspecified-consequence records; 136 synonymous variants; 193 missense variants; 8 frameshift variants; 7 stop-gained variants; 3 in-frame deletions; 1 incomplete terminal codon variant; 1 splice-region variants; 5 substitution
- Prediction scores: 781 variants have prediction scores (75% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: dengue disease, early-onset non-syndromic cataract, Partial congenital cataract, Developmental cataract, cataract, pulverulent cataract, Paralysis, hypertensive disorder, glioma, neoplasm, cancer, glioblastoma.
Protein structure and variant hotspots
- Protein features: 1 domains; 59 post-translational modification sites.
- Structural context: 607 variants have structural context.
- PTM context: 122 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable VIM variants
Examples include M1?, S2P, S2S, T3N, T3A, T3T, R4G, R4K. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV10807
- S2P (p.Ser2Pro), ExAC rs756656437, REVEL 0.33, CADD 22.80
- S2S (p.Ser2Ser), rs780501367, gnomAD 10-17229428-C-T, CADD 15.10
- T3N (p.Thr3Asn), TOPMed rs1846738793, REVEL 0.13, CADD 16.80
- T3A (p.Thr3Ala), gnomAD 10-17229429-A-G, REVEL 0.14, MetaLR 0.25
- T3T (p.Thr3Thr), gnomAD 10-17229431-C-A, CADD 15.40
- R4G (p.Arg4Gly), gnomAD rs1436554874, REVEL 0.28, CADD 23.60
- R4K (p.Arg4Lys), cosmic curated COSV56405
- R4R (p.Arg4Arg), gnomAD 10-17229432-A-C, CADD 17.40
- R4T (p.Arg4Thr), gnomAD 10-17229433-G-C, REVEL 0.16, MetaLR 0.30
- R4M (p.Arg4Met), gnomAD 10-17229433-G-T, REVEL 0.24, MetaLR 0.30
- R4S (p.Arg4Ser), gnomAD 10-17229434-G-T, REVEL 0.19, MetaLR 0.25
- S5A (p.Ser5Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S5T (p.Ser5Thr), gnomAD 10-17229435-T-A, REVEL 0.18, MetaLR 0.27
- S5S (p.Ser5Ser), rs377255736, gnomAD 10-17229437-C-T, CADD 14.80
- V6A (p.Val6Ala), gnomAD rs1230052576, REVEL 0.23, CADD 21.60
- V6M (p.Val6Met), cosmic curated COSV10879, ExAC rs755242950, gnomAD rs755242950, REVEL 0.16, CADD 20.80
- V6C (p.Val6Cys), rs864309690, gnomAD 10-17229435-TC-T, CADD 28.80
- V6L (p.Val6Leu), gnomAD 10-17229438-G-T, REVEL 0.13, MetaLR 0.26
- S7F (p.Ser7Phe), 1000Genomes rs2131679250, REVEL 0.30, CADD 23.80
- S7P (p.Ser7Pro), gnomAD 10-17229439-TG-T, CADD 25.60
- S7Y (p.Ser7Tyr), gnomAD 10-17229442-C-A, REVEL 0.32, MetaLR 0.48
- S7S (p.Ser7Ser), gnomAD 10-17229443-C-A, CADD 13.90
- S8L (p.Ser8Leu), rs779204525, ClinGen CA376174641, NCI-TCGA Cosmic COSV9981, cosmic curated COSV99813, REVEL 0.33, CADD 24.30, Uncertain significance, not provided
- S8T (p.Ser8Thr), gnomAD rs1288770216, REVEL 0.26, CADD 21.60
- S8W (p.Ser8Trp), ExAC rs779204525, gnomAD rs779204525, REVEL 0.48, CADD 26.40, Uncertain significance
- S8P (p.Ser8Pro), gnomAD 10-17229444-T-C, REVEL 0.39, MetaLR 0.49
- S8* (p.Ser8Ter), gnomAD 10-17229445-C-A, CADD 36.00
- S8S (p.Ser8Ser), gnomAD 10-17229446-G-T, CADD 14.80
- S9F (p.Ser9Phe), TOPMed rs1846739243, REVEL 0.84, CADD 31.00
- S9Y (p.Ser9Tyr), TOPMed rs1846739243
- S9T (p.Ser9Thr), gnomAD 10-17229447-T-A, REVEL 0.47, MetaLR 0.68
- S9P (p.Ser9Pro), gnomAD 10-17229447-T-C, REVEL 0.52, MetaLR 0.77
- S9S (p.Ser9Ser), gnomAD 10-17229449-C-A, CADD 15.50
- S10del (p.Ser10del), rs749805536, gnomAD 10-17229446-GTCC-, CADD 22.30
- S10P (p.Ser10Pro), gnomAD 10-17229450-T-C, REVEL 0.80, MetaLR 0.80
- S10Y (p.Ser10Tyr), gnomAD 10-17229451-C-A, REVEL 0.80, MetaLR 0.84
- S10S (p.Ser10Ser), rs748381490, gnomAD 10-17229452-C-T, CADD 16.80
- Y11C (p.Tyr11Cys), gnomAD rs1452327776
- Y11Y (p.Tyr11Tyr), gnomAD 10-17229455-C-T, CADD 15.50
- R12C (p.Arg12Cys), cosmic curated COSV10730, gnomAD rs1220895620, REVEL 0.69, CADD 25.70
- R12P (p.Arg12Pro), gnomAD rs1245254535
- R12S (p.Arg12Ser), gnomAD rs1220895620, REVEL 0.54, CADD 24.30
- R12G (p.Arg12Gly), gnomAD 10-17229456-C-G, REVEL 0.51, MetaLR 0.72
- R12H (p.Arg12His), gnomAD 10-17229457-G-A, REVEL 0.54, MetaLR 0.76
- R12L (p.Arg12Leu), gnomAD 10-17229457-G-T, REVEL 0.58, MetaLR 0.78
- R12R (p.Arg12Arg), rs1484172325, gnomAD 10-17229458-C-A, CADD 15.50
- R13K (p.Arg13Lys), gnomAD rs1846739569, REVEL 0.34, CADD 23.00
- R13S (p.Arg13Ser), Ensembl rs1031859925, REVEL 0.79, CADD 28.10
- R13G (p.Arg13Gly), gnomAD 10-17229459-A-G, REVEL 0.85, MetaLR 0.83
- R13M (p.Arg13Met), gnomAD 10-17229460-G-T, REVEL 0.76, MetaLR 0.88
- R13R (p.Arg13Arg), gnomAD 10-17229461-G-A, CADD 16.60
- M14T (p.Met14Thr), gnomAD rs1278642875, REVEL 0.38, CADD 21.70
- F15I (p.Phe15Ile), cosmic curated COSV10455
- F15L (p.Phe15Leu), NCI-TCGA Cosmic COSV5640, cosmic curated COSV56406, ExAC rs772407997, TOPMed rs772407997, REVEL 0.77, CADD 26.50, Variant assessed as somatic; moderate impact.
- F15V (p.Phe15Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F15Y (p.Phe15Tyr), TOPMed rs1846739712, REVEL 0.77, CADD 25.80
- F15F (p.Phe15Phe), rs772407997, gnomAD 10-17229467-C-T, CADD 15.90
- G16R (p.Gly16Arg), ExAC rs773471865, gnomAD rs773471865, REVEL 0.86, CADD 29.80, Uncertain significance
- G16S (p.Gly16Ser), rs773471865, ClinGen CA376174754, ClinVar RCV002272865, ExAC rs773471865, REVEL 0.68, CADD 29.20, Uncertain significance, Cataract 30
- G16C (p.Gly16Cys), gnomAD 10-17229468-G-T, REVEL 0.88, MetaLR 0.82
- G16D (p.Gly16Asp), gnomAD 10-17229469-G-A, REVEL 0.89, MetaLR 0.82
- G16G (p.Gly16Gly), gnomAD 10-17229470-C-T, CADD 11.70
- G17C (p.Gly17Cys), ExAC rs747053288, gnomAD rs747053288, REVEL 0.70, CADD 29.30
- G17S (p.Gly17Ser), gnomAD 10-17229471-G-A, REVEL 0.36, MetaLR 0.57
- G17V (p.Gly17Val), gnomAD 10-17229472-G-T, REVEL 0.73, MetaLR 0.64
- G17G (p.Gly17Gly), gnomAD 10-17229473-C-T, CADD 14.00
- P18L (p.Pro18Leu), cosmic curated COSV56407, TOPMed rs11545549, gnomAD rs11545549, REVEL 0.20, CADD 18.80
- P18R (p.Pro18Arg), TOPMed rs11545549, gnomAD rs11545549, REVEL 0.23, CADD 21.70
- P18T (p.Pro18Thr), cosmic curated COSV56405, REVEL 0.18, CADD 18.10
- P18Q (p.Pro18Gln), gnomAD 10-17229475-C-A, REVEL 0.20, MetaLR 0.33
- P18P (p.Pro18Pro), rs1415150705, gnomAD 10-17229476-G-A, CADD 5.80
- G19S (p.Gly19Ser), rs771023210, ClinGen CA5426340, ClinVar RCV004348935, ExAC rs771023210, REVEL 0.22, CADD 21.80, Uncertain significance, not specified
- G19A (p.Gly19Ala), rs1846739997, gnomAD 10-17229475-CG-C, CADD 6.59
- G19V (p.Gly19Val), gnomAD 10-17229478-G-T, REVEL 0.36, MetaLR 0.65
- G19D (p.Gly19Asp), gnomAD 10-17229478-G-A, REVEL 0.43, MetaLR 0.68
- G19G (p.Gly19Gly), rs1322281451, gnomAD 10-17229479-C-G, CADD 15.90
- T20I (p.Thr20Ile), gnomAD 10-17229481-C-T, REVEL 0.16, MetaLR 0.29
- T20T (p.Thr20Thr), rs1363106467, gnomAD 10-17229482-C-T, CADD 10.60
- A21E (p.Ala21Glu), ExAC rs776383614, gnomAD rs776383614, REVEL 0.41, CADD 16.70
- A21G (p.Ala21Gly), ExAC rs776383614, gnomAD rs776383614, REVEL 0.25, CADD 15.60
- A21T (p.Ala21Thr), NCI-TCGA TCGA novel, REVEL 0.11, CADD 19.80, Variant assessed as somatic; moderate impact.
- A21V (p.Ala21Val), ExAC rs776383614, gnomAD rs776383614, REVEL 0.24, CADD 15.90
- A21S (p.Ala21Ser), gnomAD 10-17229483-G-T, REVEL 0.16, MetaLR 0.22
- A21A (p.Ala21Ala), rs765009320, gnomAD 10-17229485-G-A, CADD 8.68
- S22I (p.Ser22Ile), NCI-TCGA Cosmic COSV9981, cosmic curated COSV99813, Variant assessed as somatic; moderate impact.
- S22R (p.Ser22Arg), gnomAD rs1202092452, REVEL 0.41, CADD 22.30
- S22S (p.Ser22Ser), gnomAD 10-17229488-C-T, CADD 15.70
- R23Q (p.Arg23Gln), Ensembl rs527439944, REVEL 0.44, CADD 24.00
- R23W (p.Arg23Trp), TOPMed rs910563895, REVEL 0.71, CADD 26.50
- R23R (p.Arg23Arg), rs910563895, gnomAD 10-17229489-C-A, CADD 16.60
- R23L (p.Arg23Leu), gnomAD 10-17229490-G-T, REVEL 0.52, MetaLR 0.33
- P24A (p.Pro24Ala), TOPMed rs1846740484
- P24L (p.Pro24Leu), cosmic curated COSV99813, REVEL 0.32, CADD 22.90
- P24S (p.Pro24Ser), gnomAD 10-17229492-C-T, REVEL 0.21, MetaLR 0.25
- P24P (p.Pro24Pro), rs1174783297, gnomAD 10-17229494-G-C, CADD 15.40
- S25R (p.Ser25Arg), Ensembl rs957631225, REVEL 0.34, CADD 23.30
- S25I (p.Ser25Ile), gnomAD 10-17229496-G-T, REVEL 0.48, MetaLR 0.43
- S25S (p.Ser25Ser), gnomAD 10-17229497-C-T, CADD 15.90
- S26C (p.Ser26Cys), Ensembl rs1846740611, REVEL 0.38, CADD 24.10
- S26P (p.Ser26Pro), gnomAD 10-17229498-T-C, REVEL 0.39, MetaLR 0.46
- S26F (p.Ser26Phe), gnomAD 10-17229499-C-T, REVEL 0.31, MetaLR 0.44
- S26Y (p.Ser26Tyr), gnomAD 10-17229499-C-A, REVEL 0.36, MetaLR 0.48
- S26S (p.Ser26Ser), rs1439751541, gnomAD 10-17229500-C-T, CADD 16.30
- S27G (p.Ser27Gly), ExAC rs775343323, TOPMed rs775343323, gnomAD rs775343323, REVEL 0.25, CADD 21.80
- S27N (p.Ser27Asn), gnomAD rs1356941925, REVEL 0.14, CADD 12.10
- S27R (p.Ser27Arg), cosmic curated COSV56406, ExAC rs775343323, TOPMed rs775343323, gnomAD rs775343323, REVEL 0.24, CADD 22.10
- S27T (p.Ser27Thr), gnomAD rs1356941925, REVEL 0.25, CADD 11.10
- S27I (p.Ser27Ile), gnomAD 10-17229502-G-T, REVEL 0.28, MetaLR 0.37
- R28G (p.Arg28Gly), rs1194887764, ClinGen CA376174915, ClinVar RCV003742422, REVEL 0.28, CADD 20.30, Uncertain significance, Cataract 30
- R28W (p.Arg28Trp), cosmic curated COSV10730, TOPMed rs1194887764, gnomAD rs1194887764, REVEL 0.32, CADD 23.90
- R28L (p.Arg28Leu), gnomAD 10-17229505-G-T, REVEL 0.25, MetaLR 0.34
- R28Q (p.Arg28Gln), gnomAD 10-17229505-G-A, REVEL 0.20, MetaLR 0.31
- R28R (p.Arg28Arg), gnomAD 10-17229506-G-T, CADD 15.50
- S29N (p.Ser29Asn), gnomAD 10-17229508-G-A, REVEL 0.35, MetaLR 0.47
- S29I (p.Ser29Ile), gnomAD 10-17229508-G-T, REVEL 0.44, MetaLR 0.47
- S29T (p.Ser29Thr), gnomAD 10-17229508-G-C, REVEL 0.29, MetaLR 0.42
- Y30C (p.Tyr30Cys), rs1846740908, ClinGen CA376174949, ClinVar RCV004154722, TOPMed rs1846740908, REVEL 0.45, CADD 23.50, Uncertain significance, not specified
- Y30Y (p.Tyr30Tyr), gnomAD 10-17229512-C-T, CADD 12.30
- V31L (p.Val31Leu), rs762644216, ClinGen CA5426345, ClinVar RCV004177932, ExAC rs762644216, REVEL 0.25, CADD 22.00, Uncertain significance, not specified
- V31V (p.Val31Val), gnomAD 10-17229515-G-T, CADD 14.80
- T32D (p.Thr32Asp), gnomAD 10-17229513-G-GT, CADD 32.00
- T33A (p.Thr33Ala), ExAC rs763707422, gnomAD rs763707422, REVEL 0.18, CADD 19.40
- T33M (p.Thr33Met), rs1344328729, NCI-TCGA Cosmic COSV9981, cosmic curated COSV99813, gnomAD rs1344328729, REVEL 0.24, CADD 22.30, Variant assessed as somatic; moderate impact.
- T33T (p.Thr33Thr), rs531385322, gnomAD 10-17229521-G-C, CADD 13.70
- S34P (p.Ser34Pro), cosmic curated COSV56406, gnomAD rs1725985429, REVEL 0.43, CADD 24.20
- S34Y (p.Ser34Tyr), Ensembl rs1846741218
- S34S (p.Ser34Ser), rs1846741261, gnomAD 10-17229524-C-T, CADD 16.50
- T35A (p.Thr35Ala), ExAC rs756711607, TOPMed rs756711607, gnomAD rs756711607, REVEL 0.27, CADD 22.40
- T35I (p.Thr35Ile), gnomAD 10-17229526-C-T, REVEL 0.33, MetaLR 0.39
- R36C (p.Arg36Cys), ExAC rs766889315, TOPMed rs766889315, gnomAD rs766889315, REVEL 0.76, CADD 31.00
- R36H (p.Arg36His), cosmic curated COSV56406, ExAC rs754236131, TOPMed rs754236131, gnomAD rs754236131, REVEL 0.61, CADD 25.70
- R36P (p.Arg36Pro), ExAC rs754236131, TOPMed rs754236131, gnomAD rs754236131, REVEL 0.64, CADD 29.60
- R36S (p.Arg36Ser), cosmic curated COSV99813, REVEL 0.45, CADD 22.70
- T37A (p.Thr37Ala), gnomAD 10-17229531-A-G, REVEL 0.09, MetaLR 0.34
- Y38H (p.Tyr38His), gnomAD 10-17229534-T-C, REVEL 0.41, MetaLR 0.61
- Y38Y (p.Tyr38Tyr), rs1238606775, gnomAD 10-17229536-C-T, CADD 14.90
- S39N (p.Ser39Asn), Ensembl rs1846741575
- L40V (p.Leu40Val), gnomAD 10-17229540-C-G, REVEL 0.26, MetaLR 0.33
- L40P (p.Leu40Pro), gnomAD 10-17229541-T-C, REVEL 0.56, MetaLR 0.43
- L40R (p.Leu40Arg), gnomAD 10-17229541-T-G, REVEL 0.54, MetaLR 0.35
- G41S (p.Gly41Ser), ExAC rs755500924, gnomAD rs755500924, REVEL 0.27, CADD 23.70
- G41R (p.Gly41Arg), gnomAD 10-17229543-G-C, REVEL 0.62, MetaLR 0.63
- G41C (p.Gly41Cys), gnomAD 10-17229543-G-T, REVEL 0.74, MetaLR 0.68
- G41G (p.Gly41Gly), gnomAD 10-17229545-C-T, CADD 16.20
- S42R (p.Ser42Arg), cosmic curated COSV10807, gnomAD rs1382854843, REVEL 0.53, CADD 23.10
- S42S (p.Ser42Ser), gnomAD 10-17229548-C-T, CADD 17.00
- A43T (p.Ala43Thr), rs748519640, ExAC rs748519640, gnomAD rs748519640, REVEL 0.20, CADD 22.10, Variant assessed as somatic; moderate impact.
- A43V (p.Ala43Val), ExAC rs758730926, TOPMed rs758730926, gnomAD rs758730926, REVEL 0.33, CADD 23.40
- A43A (p.Ala43Ala), rs1846741857, gnomAD 10-17229551-G-T, CADD 14.90
- L44P (p.Leu44Pro), TOPMed rs1318337726
- p.Leu44 Thr48del, gnomAD 10-17229549-GCGCT, CADD 22.50
- R45H (p.Arg45His), rs778098458, ClinGen CA5426356, ClinVar RCV002040136, ClinVar RCV005288563, REVEL 0.53, CADD 26.50, Uncertain significance, Cataract 30; not specified
- R45P (p.Arg45Pro), ExAC rs778098458, gnomAD rs778098458, REVEL 0.62, CADD 27.50, Uncertain significance
- R45C (p.Arg45Cys), gnomAD 10-17229555-C-T, REVEL 0.70, MetaLR 0.68
- R45L (p.Arg45Leu), gnomAD 10-17229556-G-T, REVEL 0.52, MetaLR 0.57
- R45R (p.Arg45Arg), rs771076339, gnomAD 10-17229557-C-T, CADD 16.60
- P46A (p.Pro46Ala), gnomAD 10-17229558-C-G, REVEL 0.24, MetaLR 0.46
- P46P (p.Pro46Pro), rs1279005584, gnomAD 10-17229560-C-G, CADD 16.70
- S47N (p.Ser47Asn), gnomAD rs1335964173, REVEL 0.39, CADD 23.60
- S47S (p.Ser47Ser), gnomAD 10-17229563-C-T, CADD 16.40
- T48I (p.Thr48Ile), ExAC rs745851443, TOPMed rs745851443, REVEL 0.12, CADD 19.20
- T48P (p.Thr48Pro), ExAC rs201189169, gnomAD rs201189169, REVEL 0.29, CADD 19.90
- S49G (p.Ser49Gly), ExAC rs769749512, gnomAD rs769749512, REVEL 0.20, CADD 21.80
- S49N (p.Ser49Asn), gnomAD rs1312761190, REVEL 0.43, CADD 22.60, Uncertain significance, not specified
- S49R (p.Ser49Arg), gnomAD rs1367516245, REVEL 0.41, CADD 21.90, Uncertain significance, not specified
- S49T (p.Ser49Thr), gnomAD 10-17229568-G-C, REVEL 0.13, MetaLR 0.46
- R50C (p.Arg50Cys), NCI-TCGA TCGA novel, REVEL 0.62, CADD 28.60, Variant assessed as somatic; moderate impact.
- R50H (p.Arg50His), rs11545553, NCI-TCGA Cosmic COSV5640, cosmic curated COSV56405, TOPMed rs11545553, REVEL 0.51, CADD 27.60, Variant assessed as somatic; moderate impact.
- R50A (p.Arg50Ala), rs1229957937, gnomAD 10-17229568-GC-G, CADD 25.70
- R50L (p.Arg50Leu), gnomAD 10-17229571-G-T, REVEL 0.46, MetaLR 0.67
- S51G (p.Ser51Gly), TOPMed rs1846742850, REVEL 0.23, CADD 23.20
- S51I (p.Ser51Ile), ExAC rs775190116, gnomAD rs775190116, REVEL 0.39, CADD 22.30
- S51N (p.Ser51Asn), cosmic curated COSV56405, REVEL 0.29, CADD 23.10
- S51S (p.Ser51Ser), rs1274240494, gnomAD 10-17229575-C-T, CADD 16.90
- S51R (p.Ser51Arg), gnomAD 10-17229575-C-A, REVEL 0.33, MetaLR 0.28
- L52F (p.Leu52Phe), Ensembl rs1588731496
- L52I (p.Leu52Ile), Ensembl rs1588731496, REVEL 0.07, CADD 19.30
- Y53H (p.Tyr53His), gnomAD 10-17229579-T-C, REVEL 0.36, MetaLR 0.61
- Y53* (p.Tyr53Ter), gnomAD 10-17229580-AC-A, CADD 21.80
Public VIM analysis runs
- VIM analysis run — VIM (1,040 variants) — completed 2026-08-19